User:BD2412/Undrafted/Mark S. Rosenberg

Mark S. Rosenberg is an American doctor of osteopathic medicine who served as president of the American College of Emergency Physicians.[1]

Rosenberg attended the Philadelphia College of Osteopathic Medicine from 1974 to 1978, when he received the degree of Doctor of Osteopathic Medicine.

Chairman of Emergency Medicine at St. Joseph's Regional Medical Center in Paterson, New Jersey.[1]

"He also serves as the hospital's chief innovation officer and led the development of the nation’s first Alternative to Opioids program".[1] The program established opioid alternative protocols including the use of nerve-blockers during acute pain episodes followed by non-opioid pain relievers as a substitute for the prescription of opioids. Rosenberg cited an instance of his own 93-year-old mother-in-law having been prescribed 100 Percocet tablets following treatment for wrist pain as a demonstration of the need for a change in the culture of prescription of opiates.[2]

Rosenberg was first elected to the board of directors of ACEP in 2015 and has served on the board of the Emergency Medicine Foundation, and on the National Pain Management Task Force of the U.S. Department of Health and Human Services. In addition to ALTO, Dr. Rosenberg has long been a champion for advances in palliative and geriatric care, including the ACEP Geriatric Emergency Department Accreditation program. Dr. Rosenberg earned his medical degree from the Philadelphia College of Osteopathic Medicine and is certified by the American Osteopathic Board of Emergency Medicine (AOBEM) and the American Board of Emergency Medicine (ABEM) in emergency medicine and hospice and palliative care.[3]

References

edit
  1. ^ a b c "Mark S. Rosenberg, DO, MBA, FACEP". www.acep.org.
  2. ^ David Porter and Josh Cornfield, "Alternatives to Opiates" The Grand Junction Daily Sentinel (March 29, 2016), p. 7.
  3. ^ "American College of Emergency Physicians Announces New President-Elect and Board of Directors". October 28, 2021.
edit


This open draft remains in progress as of February 15, 2022.